Hargroves Thomas Jeffrey 4
4 · Cingulate Inc. · Filed Jul 20, 2026
Research Summary
AI-generated summary of this filing
Cingulate Director Thomas Hargroves Receives 20,000-Share Option Award
What Happened
Thomas Jeffrey Hargroves, a director of Cingulate Inc. (CING), received a grant of 20,000 derivative shares (an option award) on 2026-07-16. The filing shows an acquisition price of $0.00 (no immediate cash paid). This was an award/grant (derivative), not an open-market purchase or sale.
Key Details
- Transaction date: 2026-07-16; Form 4 filed: 2026-07-20 (filed within the two-business-day reporting window).
- Transaction type/code: A (award/grant), derivative securities.
- Shares granted: 20,000; acquisition price reported: $0.00 (no cash outlay at grant).
- Shares owned after transaction: not specified in the provided filing.
- Footnote: The option vests on the earlier of (i) the one-year anniversary of the grant date or (ii) the date of Cingulate’s 2027 annual meeting of stockholders.
- No indication in the filing of an immediate sale or cashless exercise.
Context: This is a compensation-style option grant to a director that vests over time; such awards are common for board service and do not represent an open-market buy or sell. Because it’s a derivative award with a vesting condition, it does not immediately increase transferable common shares until the options vest and are exercised.
Insider Transaction Report
Form 4
Cingulate Inc.CING
Hargroves Thomas Jeffrey
Director
Transactions
- Award
Stock Option (right to Buy)
[F1]2026-07-16+20,000→ 20,000 totalExercise: $4.43Exp: 2036-07-16→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]The option vests on the earlier of (i) the one-year anniversary of the date of grant and (ii) the date of the Cingulate Inc. 2027 annual meeting of stockholders.
Signature
/s/ Shane J. Schaffer, Attorney-in-Fact|2026-07-20